Siftelic / Biotech signal desk

Read the signal before the market does.

Siftelic delivers focused biotech intelligence for decisions before the market reacts. Siftelic turns high-value primary sources into concise, actionable context for investors, analysts, and funds.

Request early access See how it works Open the live feed

Sample brief / 001

Signal found

A decision is never just a decision.

The useful part is what it changes around the company, the category, and the next catalyst.

Get the next brief

See the next biotech signal translated into the decision, companies, and catalyst it could move.

FDA decision01

Priority review accepted

Company impact02

Two names move into focus

Next monitor03

PDUFA date + launch signal

FDA decisionsClinical-trial resultsPatent eventsSEC filingsEarnings callsCompany releases

The coverage

Primary sources are abundant. Interpretation is scarce.

Biotech professionals do not need another sprawling warehouse of data. They need a sharper read on what changed, why it matters, which companies may be affected, and what to watch next.

FDA decisions01

Clinical-trial results02

Patent events03

SEC filings04

Earnings calls05

Company releases06

The method

From raw event to clear next move.

Siftelic is a translation layer for the moments that move biotech markets.

Find the change

We watch the primary sources where biotech reality changes first.

Translate the signal

Dense filings and scientific updates become a concise, decision-ready brief.

Map what moves next

See the affected companies, the market relevance, and the next thing worth monitoring.

Build your edge

Get the context before it becomes consensus.

Siftelic is opening a focused early-access circle for biotech investors, analysts, and funds. Tell us what you track.

Request access

Concise briefsSearchable intelligenceBuilt for professionals